The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

With this acquisition, LipoVation becomes a wholly owned subsidiary of Revium Rx, aligning with the company’s renewed commitment to drug delivery innovation. Revium Rx is developing a portfolio of ...

“At a time when fundamental rights are under attack across the country, we are doubling down on our commitment to safeguard ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is l ikely to drive up the cost of generic ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product DevelopmentTonix is Preparing for Potential Launch ...

A grand jury in Baton Rouge, Louisiana, has indicted and issued arrest warrants for a New York physician who prescribed ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

A New York doctor has been indicted by a Louisiana grand jury for allegedly prescribing an abortion pill online in the state, ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide ...